Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study.
Geoerger
Birgit
B
Institut Gustave Roussy, Université Paris-Sud, 39 rue Camille Desmoulins, 94805 Villejuif, France. geoerger@igr.fr
Chisholm
Julia
J
Le Deley
Marie-Cecile
MC
Gentet
Jean-Claude
JC
Zwaan
Christian Michel
CM
Dias
Nathalie
N
Jaspan
Timothy
T
Mc Hugh
Kieran
K
Couanet
Dominique
D
Hain
Sharon
S
Devos
Annick
A
Riccardi
Riccardo
R
Cesare
Colosimo
C
Boos
Joachim
J
Frappaz
Didier
D
Leblond
Pierre
P
Aerts
Isabelle
I
Vassal
Gilles
G